Atara Biotherapeutics
ATRA
#9995
Rank
โ‚น7.25 B
Marketcap
โ‚น804.82
Share price
2.42%
Change (1 day)
-10.86%
Change (1 year)

Revenue for Atara Biotherapeutics (ATRA)

Revenue in 2026 (TTM): โ‚น2.00 Billion

According to Atara Biotherapeutics's latest financial reports the company's current revenue (TTM ) is โ‚น2.20 Billion. In 2025 the company made a revenue of โ‚น10.84 Billion a decrease over the revenue in the year 2024 that were of โ‚น11.06 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Atara Biotherapeutics from 2013 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น2.00 B-81.51%
2025 โ‚น10.84 B-1.99%
2024 โ‚น11.06 B1449.87%
2023 โ‚น0.71 B-86.43%
2022 โ‚น5.26 B247.48%
2021 โ‚น1.51 B
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A
2013 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ImmunoGen
IMGN
โ‚น27.39 B 1,142.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
โ‚น11.79 B 435.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Affimed
AFMD
โ‚น91.6 M-95.84%๐Ÿ‡ฉ๐Ÿ‡ช Germany